InvestorsHub Logo
Followers 48
Posts 5517
Boards Moderated 0
Alias Born 09/04/2009

Re: zumantu post# 43011

Saturday, 02/28/2015 9:09:41 AM

Saturday, February 28, 2015 9:09:41 AM

Post# of 423975
Zum, in the latest Amarin's press release on Feb 26, it contains the following language regarding REDUCE-IT (4th paragraph):

"REDUCE-IT enrollment of an estimated 8,000 patients is expected to be completed in 2015, with a protocol pre-specified interim data analysis of efficacy and safety results at 60% of targeted events anticipated in 2016 by the independent Data Monitoring Committee (DMC). Completion of the REDUCE-IT study, if not stopped earlier based on the interim analysis by the independent DMC, is expected in 2017 with published results expected to be available in 2018."

That shows me increased confidence by Amarin's management regarding interim R-I data not previously shown.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AMRN News